Literature DB >> 21045318

Crystallization and preliminary X-ray diffraction analysis of the protease from Southampton norovirus complexed with a Michael acceptor inhibitor.

R J Hussey1, L Coates, R S Gill, J N Wright, M Sarwar, S Coker, P T Erskine, J B Cooper, S Wood, I N Clarke, P R Lambden, R Broadbridge, P M Shoolingin-Jordan.   

Abstract

Noroviruses are the predominant cause of human epidemic nonbacterial gastroenteritis. Viral replication requires a cysteine protease that cleaves a 200 kDa viral polyprotein into its constituent functional parts. Here, the crystallization of the recombinant protease from the Southampton norovirus is described. Whilst the native crystals were found to diffract only to medium resolution (2.9 Å), cocrystals of an inhibitor complex diffracted X-rays to 1.7 Å resolution. The polypeptide inhibitor (Ac-EFQLQ-propenyl ethyl ester) possesses an amino-acid sequence designed to match the substrate specificity of the enzyme, but was synthesized with a reactive Michael acceptor group at the C-terminal end.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21045318      PMCID: PMC3001671          DOI: 10.1107/S1744309110039059

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  20 in total

1.  Inactivation of cysteine proteases.

Authors:  C P Govardhan; R H Abeles
Journal:  Arch Biochem Biophys       Date:  1996-06-01       Impact factor: 4.013

2.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

3.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

4.  Polyprotein processing in Southampton virus: identification of 3C-like protease cleavage sites by in vitro mutagenesis.

Authors:  B Liu; I N Clarke; P R Lambden
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  Sequence and genome organization of a human small round-structured (Norwalk-like) virus.

Authors:  P R Lambden; E O Caul; C R Ashley; I N Clarke
Journal:  Science       Date:  1993-01-22       Impact factor: 47.728

6.  Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies.

Authors:  P S Dragovich; S E Webber; R E Babine; S A Fuhrman; A K Patick; D A Matthews; C A Lee; S H Reich; T J Prins; J T Marakovits; E S Littlefield; R Zhou; J Tikhe; C E Ford; M B Wallace; J W Meador; R A Ferre; E L Brown; S L Binford; J E Harr; D M DeLisle; S T Worland
Journal:  J Med Chem       Date:  1998-07-16       Impact factor: 7.446

7.  Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies.

Authors:  P S Dragovich; S E Webber; R E Babine; S A Fuhrman; A K Patick; D A Matthews; S H Reich; J T Marakovits; T J Prins; R Zhou; J Tikhe; E S Littlefield; T M Bleckman; M B Wallace; T L Little; C E Ford; J W Meador; R A Ferre; E L Brown; S L Binford; D M DeLisle; S T Worland
Journal:  J Med Chem       Date:  1998-07-16       Impact factor: 7.446

8.  Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics.

Authors:  Peter S Dragovich; Thomas J Prins; Ru Zhou; Theodore O Johnson; Ye Hua; Hiep T Luu; Sylvie K Sakata; Edward L Brown; Fausto C Maldonado; Tove Tuntland; Caroline A Lee; Shella A Fuhrman; Leora S Zalman; Amy K Patick; David A Matthews; Ellen Y Wu; Ming Guo; Bennett C Borer; Naresh K Nayyar; Terence Moran; Lijian Chen; Paul A Rejto; Peter W Rose; Mark C Guzman; Elena Z Dovalsantos; Steven Lee; Kevin McGee; Michael Mohajeri; Andreas Liese; Junhua Tao; Maha B Kosa; Bo Liu; Minerva R Batugo; Jean-Paul R Gleeson; Zhen Ping Wu; Jia Liu; James W Meador; Rose Ann Ferre
Journal:  J Med Chem       Date:  2003-10-09       Impact factor: 7.446

Review 9.  The integration of macromolecular diffraction data.

Authors:  Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

Review 10.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14
View more
  2 in total

1.  Substrate specificity of Tulane virus protease.

Authors:  Chao Wei; Jarek Meller; Xi Jiang
Journal:  Virology       Date:  2012-11-08       Impact factor: 3.616

2.  Structure-based design and functional studies of novel noroviral 3C protease chimaeras offer insights into substrate specificity.

Authors:  Morgan R Herod; Cynthia A Prince; Rachel J Skilton; Vernon K Ward; Jonathan B Cooper; Ian N Clarke
Journal:  Biochem J       Date:  2014-12-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.